system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, RESULTS, METHODS. Meshes: Aldehyde Dehydrogenase, Apoferritins, Cell Line, Tumor, Cell Movement, Cell Proliferation, Cell Survival, Epithelial-Mesenchymal Transition, Female, Gene Expression Regulation, Neoplastic, Gene Silencing, Humans, Lipid Metabolism, MCF-7 Cells, MicroRNAs, Nanog Homeobox Protein, Neoplastic Stem Cells, Octamer Transcription Factor-3, Ovarian Neoplasms, Prognosis, Stearoyl-CoA Desaturase, Vimentin.
user
Is ferritin heavy chain a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition? Context: Ferritin is the major intracellular iron storage protein essential for maintaining the cellular redox status. In recent years ferritin heavy chain (FHC) has been shown to be involved also in the control of cancer cell growth. Analysis of public microarray databases in ovarian cancer revealed a correlation between low FHC expression levels and shorter survival. To better understand the role of FHC in cancer, we have silenced the FHC gene in SKOV3 cells. FHC-KO significantly enhanced cell viability and induced a more aggressive behaviour. FHC-silenced cells showed increased ability to form 3D spheroids and enhanced expression of NANOG, OCT4, ALDH and Vimentin. These features were accompanied by augmented expression of SCD1, a major lipid metabolism enzyme. FHC apparently orchestrates part of these changes by regulating a network of miRNAs. FHC-silenced and control shScr SKOV3 cells were monitored for changes in proliferation, migration, ability to propagate as 3D spheroids and for the expression of stem cell and epithelial-to-mesenchymal-transition (EMT) markers. The expression of three miRNAs relevant to spheroid formation or EMT was assessed by q-PCR.
assistant
In this paper we uncover a new function of FHC in the control of cancer stem cells. Final Decision: yes